A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)
| Image |  |
|---|---|
| Description | scientific article published on July 23, 2012 |
| Author/s | |
| Publication date | July 23, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-12-307 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |